Cost of introducing and delivering malaria vaccine (RTS,S/AS01E) in areas of seasonal malaria transmission, Mali and Burkina Faso

Cost of introducing and delivering malaria vaccine (RTS,S/AS01E) in areas of seasonal malaria transmission, Mali and Burkina Faso

Background The WHO recommends use of the RTS,S/AS01E (RTS,S) malaria vaccine for young children living in areas of moderate to high Plasmodium falciparum malaria transmission and suggests countries consider seasonal vaccination in areas with highly seasonal malaria. Seasonal vaccination is uncommon...

Full description

Bibliographic Details
Main Authors:	Jean Bosco Ouédraogo, Alassane Dicko, Ranju Baral, Clint Pecenka, Halimatou Diawara, Fadima Yaya Bocoum, Ann Levin, Cynthia Lee, Fatoumata Koita, Rosemonde Guissou, Seydou Yabré, Seydou Traoré, Winthrop Morgan
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-04-01
Series:	BMJ Global Health
Online Access:	https://gh.bmj.com/content/8/4/e011316.full

Similar Items

Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context
by: Jayne Webster, et al.
Published: (2025-02-01)

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
by: Ranju Baral, et al.
Published: (2021-01-01)

THE RTS,S MALARIA VACCINE What is the efficacy of the RTS,S malaria vaccine?
by: Duncan, C, et al.
Published: (2011)

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01E
by: M. Sanni Ali, et al.
Published: (2025-02-01)

What is the efficacy of the RTS,S malaria vaccine?
by: Duncan, C, et al.
Published: (2011)

What is the efficacy of the RTS,S malaria vaccine?
by: Duncan, C, et al.
Published: (2011)

Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso
by: Kadiatou Koita, et al.
Published: (2024-01-01)

Stakeholder engagement in the development of genetically modified mosquitoes for malaria control in West Africa: lessons learned from 10 years of Target Malaria’s work in Mali
by: Bakara Dicko, et al.
Published: (2024-01-01)

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
by: Ismaila Thera, et al.
Published: (2020-09-01)

RTS,S/AS01 malaria vaccine in African children.
by: Hill, A
Published: (2012)

Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial
by: Dicko, A, et al.
Published: (2016)

Effect of Seasonality and Ecological Factors on the Prevalence of the Four Malaria Parasite Species in Northern Mali
by: Ousmane A. Koita, et al.
Published: (2012-01-01)

Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective
by: Rachel Wittenauer, et al.
Published: (2023-03-01)

Effects of feed and health interventions on small ruminant production in mixed crop-livestock systems in Southern Mali
by: Augustine A. Ayantunde, et al.
Published: (2019-07-01)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
by: Bejon, P, et al.
Published: (2009)

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
by: Gosling, R, et al.
Published: (2015)

Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond
by: Elizabeth Adrianne Hammershaimb, et al.
Published: (2024-12-01)

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01 E
by: Ali, MS, et al.
Published: (2025)

The efficacy of attractive targeted sugar baits in reducing malaria vector abundance in low-endemicity settings of northwest Mali
by: Mohamed M. Traore, et al.
Published: (2024-10-01)

Prognostics of multiple malaria episodes and nutritional status in children aged 6 to 59 months from 2013 to 2017 in Dangassa, Koulikoro region, Mali
by: Soumba Keita, et al.
Published: (2024-06-01)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
by: Hassan Mumtaz, et al.
Published: (2023-06-01)

Irrational medicine use and its associated factors in conflict-affected areas in Mali: a cross-sectional study
by: Mohamed Ali Ag Ahmed, et al.
Published: (2025-12-01)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
by: Olotu, A, et al.
Published: (2010)

The clinical profile of severe paediatric malaria in an area targeted for routine RTS,S/AS01 malaria vaccination in Western Kenya
by: Akech, S, et al.
Published: (2019)

Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali and Niger
by: Anyirékun Fabrice Somé, et al.
Published: (2022-08-01)

Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model
by: Ranju Baral, et al.
Published: (2021-04-01)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
by: Corinne S. Merle, et al.
Published: (2023-08-01)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
by: Agnandji, S, et al.
Published: (2012)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
by: Olotu, A, et al.
Published: (2016)

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
by: Olotu, A, et al.
Published: (2013)

Influence of trust on the acceptance of the RTS,S malaria vaccine in the Kassena-Nankana districts of Ghana
by: Eustace Bugase, et al.
Published: (2024-11-01)

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
by: Philippe Moris, et al.
Published: (2018-01-01)

Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: A review of literature
by: Abdullah Nadeem, et al.
Published: (2023-01-01)

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
by: Bejon, P, et al.
Published: (2013)

Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data
by: Bejon, P, et al.
Published: (2013)

Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa
by: Galactionova, K, et al.
Published: (2017)

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
by: Agnandji, S, et al.
Published: (2011)

Type 2 diabetes prevalence, awareness, and risk factors in rural Mali: a cross-sectional study
by: Abdoulaye Diawara, et al.
Published: (2023-03-01)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
by: Bejon, P, et al.
Published: (2008)

RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype
by: Nielsen, C, et al.
Published: (2018)